Fluorescent Viral Particles for Rapid Clearance Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating viral clearance in biological medical product preparation processes are costly, time-consuming, and logistically complex, with a high risk of failure leading to delays in regulatory approval.
Innovation Solution
The use of fluorescent viral particles, which are viral particles conjugated with a fluorescent dye, as test contaminants to challenge purification processing in biological medical product preparation processes, allowing for rapid and consistent quantification of viral removal efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional viral clearance evaluation methods (infectivity assays, qPCR, ELISA) are used, then viral contaminant removal can be demonstrated, but the process is costly, time-consuming, and logistically complex
Solution Approach 1:
The patent uses fluorescent viral particles as simplified copies or surrogates of actual viral contaminants. These fluorescent particles replicate the physical properties and behavior of real viruses during purification processes but include a fluorescent marker for easy detection, eliminating the need for complex infectivity assays while maintaining clearance demonstration reliability
Solution Approach 2:
The patent replaces complex biological and chemical detection systems (infectivity assays, qPCR, ELISA) with a simple fluorescent detection system. The fluorescent viral particles allow direct visualization and quantification through fluorescence measurement, substituting multi-step mechanical and biochemical procedures with a single optical measurement step
2Reliability
If conventional viral clearance evaluation methods are used, then viral contaminant removal can be demonstrated, but the process is time-consuming and expensive
Solution Approach 1:
The fluorescent viral particles serve as time-efficient surrogates that can be detected immediately after purification without requiring lengthy incubation periods, complex sample preparation, or multi-day assay protocols. The fluorescent signal provides instant quantification of viral particle removal
Solution Approach 2:
The fluorescent viral particles are pre-labeled with fluorescent dyes before use in clearance studies. This preliminary fluorescent tagging eliminates the need for post-purification labeling steps and allows direct detection, significantly reducing the overall evaluation time compared to conventional methods that require multiple sequential steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient evaluation of viral contaminant removal, reducing the complexity and cost of viral clearance studies, while providing a robust and versatile testing platform for various virus purification techniques.
Implementation Method 1
fluorescent viral particles, including viral particles and a fluorescent dye conjugated to the viral particles
Data Source
AI summary
Fluorescent viral particles, including viral particles and a fluorescent dye conjugated to the viral particles, are used for viral contaminant removal testing as part of viral clearance evaluation for biological medical product preparation processes. The conjugated fluorescent dye adds only marginally to viral particle size, but provides versatility both for rapid screening of alternative viral removal approaches during process development and for final process validation, as the fluorescent viral particles have fluorescent activity throughout the viral clearance evaluation process, permitting rapid and consistent quantification of initial test solutions, resulting purified solutions, and intermediate solutions of interest at any point during processing under evaluation.